What are the risks of malignancies due to having IBD and being on immunomodulators and/or biologics: How can we help our patients avoid those risks?

08/07/2018

Related Content

Stress and Burnout
Stress and Burnout
David Hudesman, MD, on Reducing Stress and Risk Among Staff
04/27/2020
In this video, Gastroenterology Consultant Advisory Board Member David Hudesman, MD, talks about how his staff is coping with COVID-19 challenges, as well as how he helps his staff reduce stress and risk of...
04/27/2020
Gastroenterology
Gastroenterology
CCIBD2017_Discussion
07/31/2018
07/31/2018
Inflammatory Bowel Disease
Strong
Inflammatory Bowel Disease
Scott Strong, MD, on Preparing Patients With IBD for Surgery
07/25/2020
He discusses his presentation at the virtual Advances in Inflammatory Bowel Disease 2020 regional meeting July 25 on preparing patients with IBD for surgery.
07/25/2020
Immunology
Immunology
Benefits of Human Milk Oligosaccharides
08/03/2017
Rachael Buck, PhD, discusses the potential of a new infant formula she and her research team developed, which harnesses the unique qualities and benefits of human milk oligosaccharides (an alternative...
08/03/2017
Gastroenterology
Gastroenterology
How to Induce and Maintain Remission Using Biologics
08/01/2018
08/01/2018